177 related articles for article (PubMed ID: 9856804)
1. Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin.
Kiguchi K; Kagehara M; Higo R; Iwamori M; DiGiovanni J
J Invest Dermatol; 1998 Dec; 111(6):973-81. PubMed ID: 9856804
[TBL] [Abstract][Full Text] [Related]
2. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
[TBL] [Abstract][Full Text] [Related]
4. Activation of epidermal akt by diverse mouse skin tumor promoters.
Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.
Chida K; Murakami A; Tagawa T; Ikuta T; Kuroki T
Cancer Res; 1995 Nov; 55(21):4865-9. PubMed ID: 7585521
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
9. Elevation of transforming growth factor-alpha mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis.
Kiguchi K; Beltrán LM; You J; Rho O; DiGiovanni J
Mol Carcinog; 1995 Apr; 12(4):225-35. PubMed ID: 7727044
[TBL] [Abstract][Full Text] [Related]
10. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
13. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
14. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
15. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
DiGiovanni J; Bol DK; Wilker E; Beltrán L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K
Cancer Res; 2000 Mar; 60(6):1561-70. PubMed ID: 10749124
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase and skin tumor promotion.
Ahmad N; Srivastava RC; Agarwal R; Mukhtar H
Biochem Biophys Res Commun; 1997 Mar; 232(2):328-31. PubMed ID: 9125174
[TBL] [Abstract][Full Text] [Related]
18. Effect of diverse tumor promoters on the expression of gap-junctional proteins connexin (Cx)26, Cx31.1, and Cx43 in SENCAR mouse epidermis.
Budunova IV; Carbajal S; Slaga TJ
Mol Carcinog; 1996 Mar; 15(3):202-14. PubMed ID: 8597533
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice.
Rho O; Beltrán LM; Gimenez-Conti IB; DiGiovanni J
Mol Carcinog; 1994 Sep; 11(1):19-28. PubMed ID: 7916986
[TBL] [Abstract][Full Text] [Related]
20. RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.
Luke CT; Oki-Idouchi CE; Cline JM; Lorenzo PS
Cancer Res; 2007 Nov; 67(21):10190-7. PubMed ID: 17974959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
